CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $629,000 | -5.1% | 34,241 | -5.3% | 0.00% | – |
| Q3 2020 | $663,000 | +18.4% | 36,148 | -3.3% | 0.00% | – |
| Q2 2020 | $560,000 | -0.5% | 37,396 | +5.0% | 0.00% | – |
| Q1 2020 | $563,000 | -0.7% | 35,629 | +2.0% | 0.00% | – |
| Q4 2019 | $567,000 | +16.7% | 34,920 | +6.7% | 0.00% | – |
| Q3 2019 | $486,000 | -24.1% | 32,724 | -15.4% | 0.00% | – |
| Q2 2019 | $640,000 | -5.0% | 38,684 | -0.7% | 0.00% | – |
| Q1 2019 | $674,000 | +0.7% | 38,959 | +2.9% | 0.00% | – |
| Q4 2018 | $669,000 | +13.2% | 37,857 | +16.3% | 0.00% | – |
| Q3 2018 | $591,000 | -12.6% | 32,549 | -5.9% | 0.00% | – |
| Q2 2018 | $676,000 | +243.1% | 34,579 | +208.1% | 0.00% | – |
| Q1 2018 | $197,000 | -58.5% | 11,225 | -72.1% | 0.00% | – |
| Q1 2017 | $475,000 | -8.1% | 40,268 | +1.9% | 0.00% | – |
| Q4 2016 | $517,000 | -3.2% | 39,506 | +7.2% | 0.00% | – |
| Q3 2016 | $534,000 | +17.9% | 36,865 | -2.2% | 0.00% | – |
| Q2 2016 | $453,000 | -26.1% | 37,713 | +14.8% | 0.00% | – |
| Q1 2016 | $613,000 | -12.3% | 32,845 | +0.9% | 0.00% | – |
| Q4 2015 | $699,000 | +26.9% | 32,555 | 0.0% | 0.00% | – |
| Q3 2015 | $551,000 | -57.9% | 32,555 | -6.7% | 0.00% | – |
| Q2 2015 | $1,309,000 | +526.3% | 34,897 | +426.5% | 0.00% | – |
| Q1 2015 | $209,000 | – | 6,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|